Cadrenal Therapeutics Inc Com New

CUSIP 127636108StockCVKDQ4 2025

Cadrenal Therapeutics Inc Com New — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

48.6%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 14, 2024

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 14, 2024	Armistice Capital, LLC	13G	10.0%	1.40M	SEC
2	Feb 13, 2024	Murphy John Raymond	13G/A	5.5%	714.8K	SEC
3	Feb 12, 2024	Pham Quang X	13G	48.6%	6.33M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Farther Finance Advisors, LLC	25	$170
2	Caldwell Sutter Capital, Inc.	5	$34